Showing 117 of 117on this page. Filters & sort apply to loaded results; URL updates for sharing.117 of 117 on this page
Embecta Corp. Dividend History & Metrics
Embecta Stock Split History
Embecta Corp. (EMBC) Stock Price, News, Quote & History - Yahoo Finance
BD spinoff Embecta looks to build on 100 years of diabetes technology ...
Great to see the embecta logo unveiled on the building! | Naomi Redmond
embecta
embecta announces FDA clearance of its disposable patch pump
Embecta Corp's Dividend Analysis
embecta | brand launch | Campaign
Canada. 22nd May, 2025. In this photo illustration, the Embecta logo is ...
Embecta Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag
Investor Overview | embecta Corp. | Nasdaq
Embecta opens new global headquarters in New Jersey - Medical Buyer
Embecta Corp. - AnnualReports.com
Embecta Corp. 2023 Q1 - Results - Earnings Call Presentation (NASDAQ ...
Buy Embecta Corp Stock – EMBC Stock Quote Today & Investment Insights ...
Embecta Brand Launch - Learn About The Final Impact
Here's What Embecta Corp.'s (NASDAQ:EMBC) Shareholder Ownership ...
About embecta™ - Discover Our Mission & History
Embecta opens new global headquarters in New Jersey
Discover Our Diabetes Care Products & Learn About EMBECTA
Embecta Growth Stalls Despite Strong Fiscal 2025 Results (NASDAQ:EMBC ...
It’s official - embecta is Certified™ by Great Place To Work® in the ...
Embecta Corp. $EMBC Shares Sold by State of Alaska Department of Revenue
Embecta logo in transparent PNG format
Investor Overview | embecta Corp.
How Embecta started strong as a standalone company
Embecta Corp. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ ...
Embecta Corp. (EMBC) Presents at 44th Annual J.P. Morgan Healthcare ...
Embecta Corp. - ResponsibilityReports.com
Embecta Corp. Q2 2026 Earnings Call Summary
Journée mondiale du diabète avec embecta - Medytec
embecta Japan wins award for mobile app that supports diabetes patients ...
Embecta Q2 2025 slides: Revenue decline offset by margin improvement ...
Embecta (EMBC) Company Profile, History, Products & Services
embecta launches educational programme to combat diabetes in Asia ...
Embecta Corp (EMBC) Surpasses Analyst Revenue Forecasts in Q2 Fiscal 2024
Diabetes Foundation joins Embecta in ringing Nasdaq opening bell | ROI-NJ
Embecta (EMBC) Stock Price & Overview
Embecta gets FDA nod for insulin patch pump | MedTech Dive
Embecta Acquires Owen Mumford for $199.4M to Bolster Drug Delivery and ...
Embecta Corp. Stock Report — EMBC Analysis — Roic AI
Embecta expands diabetes partnership with Direct Relief
Deeply Undervalued Global Medical Device Company – Embecta Corp. (EMBC ...
Embecta Corp. (NASDAQ:EMBC) Q4 2024 Earnings Call Transcript - Insider ...
Embecta Corp's Q2 2025 Earnings: Navigating Headwinds with Strategic ...
In 2025, embecta made significant strides in aligning our operations ...
Embecta Announces Halt in Insulin Patch Pump Innovation
Embecta wins FDA clearance for disposable insulin patch pump – Start ...
State Street Increases Position in Embecta (EMBC.V) | Nasdaq
Embecta logo in transparent PNG and vectorized SVG formats
embecta, 100 years | embecta
Embecta Corp - WKN A3DGNE, ISIN US29082K1051 | DivvyDiary
embecta - GPTWⓇ MÉXICO
Embecta Q3 Earnings: Revenue Jumps 8.4%, Raises Full-Year Guidance ...
Embecta | Discover Creative Excellence – Engage Now — Agency MJ
Embecta Medical
Embecta Stock Gains on FDA Clearance for Type 2 Diabetes Insulin Pump
Embecta Ultra-Fine Pen Needles
Intuity Medical and embecta Launch Commercial Collaboration, Expanding ...
Embecta Ultra-Fine Insulin Syringes
In this photo illustration, a smartphone with the logo of US medical ...
FDA Approves Embecta's New Insulin-Delivery System for Both Type 1 and ...
Discover Our Diabetes Care Products & Learn About embecta™
While insulin injections continue to be essential to diabetes care, we ...
Careers
Embecta’s Bold Move: Will This Insulin Needle Giant Be the Next Big ...
New Packaging
Slide 6
关于embecta™ - 了解我们的使命和历史
Join our fourth quarter fiscal year 2023 earnings call tomorrow at 7 ...
